Joseph J. Reilly - 23 Jan 2026 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 Jan 2026, 16:13:38 UTC
Prior SEC filing
25 Nov 2025
Next SEC filing
23 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Joseph J. Reilly

Key filing fact

Joseph J. Reilly filed Form 4 for ARDELYX, INC. (ARDX) on 27 Jan 2026.

Key facts

  • This page summarizes Joseph J. Reilly's Form 4 filing for ARDELYX, INC. (ARDX).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Jan 2026, 16:13.

Change

  • Previous filing in this sequence was filed on 25 Nov 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002044416 Primary reporting owner

Reilly Joseph James

Relationship
Senior Vice President of Finance
Address
C/O ARDELYX, INC., 400 FIFTH AVENUE, SUITE 210, WALTHAM
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for Joseph J. Reilly
Signature date
27 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARDX transaction

Common Stock

Award

Transaction value
$0
Shares
+46,200
Change %
+42%
Price
$0.000000
Shares after
156,781
Date
23 Jan 2026
Ownership
Direct
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARDX transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+69,360
Change %
Price
$0.000000
Shares after
69,360
Date
23 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
69,360
Exercise price
$7.77
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted stock units ("RSUs"). The Reporting Person is entitled to receive one (1) shares of Common Stock for each one (1) RSU upon the vesting thereof.

Footnote F2

Includes the purchase of 1,667 shares under the Ardelyx Employee Stock Purchase Plan on August 31, 2025.

Footnote F3

The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 23, 2026, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

SEC remarks

Senior Vice President of Finance

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .